Xiao-Shan Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiao-Shan Guo has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Hua Wei
First Hospital of Shanxi Medical University
1 shared publicationKeyi Lu
First Hospital of Shanxi Medical University
1 shared publication- Li Xu
First Hospital of Shanxi Medical University
1 shared publication Nan Huang
First Hospital of Shanxi Medical University
1 shared publication- Ping Wu
Collaborative Innovation Center for Molecular Imaging of Precision Medicine, Shanxi Medical University, 030000 Taiyuan, Shanxi, China
1 shared publication - Qiuyan Wu
First Hospital of Shanxi Medical University
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by Springer Nature in Research Square
Prognostic Heterogeneity in Intermediate-Risk Papillary Thyroid Cancer: Surgery, Radioiodine, and Reclassification Using the 2025ATA Risk Stratification System
Background The 2015 American Thyroid Association (ATA) intermediate-risk category for papillary thyroid carcinoma (PTC) includes patients with heterogeneous outcomes, creating uncertainty regarding surgical extent and postoperative radioactive iodine (RAI). This study evaluated associations of surgical extent and RAI with structural recurrence-free survival (sRFS) and assessed prognostic stratification using the 2025 ATA system. Methods We retrospectively analyzed 454 patients with PTC treated between January 2018 and December 2021 who met the 2015 ATA intermediate-risk criteria. Patients underwent lobectomy without RAI (n = 68), total thyroidectomy without RAI (n = 102), or total thyroidectomy followed by RAI (n = 284). One-to-one propensity score matching (PSM) was performed for lobectomy versus total thyroidectomy and for total thyroidectomy with versus without RAI. All patients were reclassified according to the 2025 ATA system. Results After PSM, sRFS did not differ significantly between lobectomy and total thyroidectomy (P = 0.487) or between total thyroidectomy with and without RAI (P = 0.744). Reclassification assigned 1 patient (0.2%) to low risk, 123 (27.1%) to low-intermediate risk, 322 (70.9%) to intermediate-high risk, and 8 (1.8%) to high risk. Structural event rates were 0%, 12.2%, 17.4%, and 50.0%, respectively, with significant differences across strata (log-rank P = 0.039). Conclusion The 2015 ATA intermediate-risk category showed substantial prognostic heterogeneity. Neither more extensive surgery nor postoperative RAI was associated with improved sRFS after PSM. The 2025 ATA system further separated this population into prognostically distinct groups, although treatment-specific benefits within these strata were not evaluated.
- 12 November 2026
- Published by Springer Nature in Research Square
Open AccessPrognostic Heterogeneity in Intermediate-Risk Papillary Thyroid Cancer: Surgery, Radioiodine, and Reclassification Using the 2025ATA Risk Stratification System
Background The 2015 American Thyroid Association (ATA) intermediate-risk category for papillary thyroid carcinoma (PTC) includes patients with heterogeneous outcomes, creating uncertainty regarding surgical extent and postoperative radioactive iodine (RAI). This study evaluated associations of surgical extent and RAI with structural recurrence-free survival (sRFS) and assessed prognostic stratification using the 2025 ATA system. Methods We retrospectively analyzed 454 patients with PTC treated between January 2018 and December 2021 who met the 2015 ATA intermediate-risk criteria. Patients underwent lobectomy without RAI (n = 68), total thyroidectomy without RAI (n = 102), or total thyroidectomy followed by RAI (n = 284). One-to-one propensity score matching (PSM) was performed for lobectomy versus total thyroidectomy and for total thyroidectomy with versus without RAI. All patients were reclassified according to the 2025 ATA system. Results After PSM, sRFS did not differ significantly between lobectomy and total thyroidectomy (P = 0.487) or between total thyroidectomy with and without RAI (P = 0.744). Reclassification assigned 1 patient (0.2%) to low risk, 123 (27.1%) to low-intermediate risk, 322 (70.9%) to intermediate-high risk, and 8 (1.8%) to high risk. Structural event rates were 0%, 12.2%, 17.4%, and 50.0%, respectively, with significant differences across strata (log-rank P = 0.039). Conclusion The 2015 ATA intermediate-risk category showed substantial prognostic heterogeneity. Neither more extensive surgery nor postoperative RAI was associated with improved sRFS after PSM. The 2025 ATA system further separated this population into prognostically distinct groups, although treatment-specific benefits within these strata were not evaluated.
- Open Access
- 3 September 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (17) , e032169
Prognostic Value of Resting Left Ventricular Sphericity Indexes in Coronary Artery Disease With Preserved Ejection Fraction
Background: Adverse left ventricular remodeling is a significant cardiovascular predictor for patients with coronary artery disease and preserved left ventricular ejection fraction (LVEF). However, the remodeling indexes reflecting left ventricular spherization by myocardial perfusion imaging are underexplored. Methods and Results: 727 patients (mean age 59.8±13.5 years, 329 women) diagnosed or suspected coronary artery disease with preserved LVEF who underwent resting myocardial perfusion imaging were retrospectively enrolled. The myocardial perfusion imaging findings including the total perfusion deficit and sphericity indexes (shape index (SI) and eccentricity index (EI) obtained from gated (QGS) and non‐gated (QPS) images) were collected. Major adverse cardiovascular events (MACE) were followed up for 45.1±22.0 months. All patients were divided into 4 subgroups based on total perfusion deficit at 10% and LVEF at 65%. Univariable comparative analyses were performed in 5 cohorts (all patients and 4 subgroups). Patients who experienced MACE displayed higher SI and/or lower EI (all P QPS in all 5 cohorts, for EI QPS and EI QGS in 4 cohorts, and for end‐systolic and end‐diastolic SI QGS in 3 cohorts (all P QPS is particularly promising across different perfusion or preserved functional conditions.
- 3 September 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (17) , e032169
Open AccessPrognostic Value of Resting Left Ventricular Sphericity Indexes in Coronary Artery Disease With Preserved Ejection Fraction
Background: Adverse left ventricular remodeling is a significant cardiovascular predictor for patients with coronary artery disease and preserved left ventricular ejection fraction (LVEF). However, the remodeling indexes reflecting left ventricular spherization by myocardial perfusion imaging are underexplored. Methods and Results: 727 patients (mean age 59.8±13.5 years, 329 women) diagnosed or suspected coronary artery disease with preserved LVEF who underwent resting myocardial perfusion imaging were retrospectively enrolled. The myocardial perfusion imaging findings including the total perfusion deficit and sphericity indexes (shape index (SI) and eccentricity index (EI) obtained from gated (QGS) and non‐gated (QPS) images) were collected. Major adverse cardiovascular events (MACE) were followed up for 45.1±22.0 months. All patients were divided into 4 subgroups based on total perfusion deficit at 10% and LVEF at 65%. Univariable comparative analyses were performed in 5 cohorts (all patients and 4 subgroups). Patients who experienced MACE displayed higher SI and/or lower EI (all P QPS in all 5 cohorts, for EI QPS and EI QGS in 4 cohorts, and for end‐systolic and end‐diastolic SI QGS in 3 cohorts (all P QPS is particularly promising across different perfusion or preserved functional conditions.